Crescent Biopharma, Inc. (CBIO)
CBIO Stock Price Chart
Explore Crescent Biopharma, Inc. interactive price chart. Choose custom timeframes to analyze CBIO price movements and trends.
CBIO Company Profile
Discover essential business fundamentals and corporate details for Crescent Biopharma, Inc. (CBIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Jan 2014
Employees
33.00
Website
https://crescentbiopharma.comCEO
Joshua T. Brumm
Description
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
CBIO Financial Timeline
Browse a chronological timeline of Crescent Biopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Jul 2025
EPS came in at -$4.93 falling short of the estimated -$2.69 by -83.27%.
Stock split effective on 16 Jun 2025
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2025
EPS came in at -$0.04 .
Earnings released on 3 Nov 2023
EPS came in at -$14.00 matching the estimated -$14.00.
Earnings released on 2 Aug 2023
EPS came in at -$13.00 surpassing the estimated -$18.00 by +27.78%.
Earnings released on 3 May 2023
EPS came in at -$17.00 matching the estimated -$17.00.
Earnings released on 9 Nov 2022
EPS came in at -$16.00 surpassing the estimated -$26.00 by +38.46%.
Earnings released on 3 Aug 2022
EPS came in at -$25.00 surpassing the estimated -$29.00 by +13.79%.
Earnings released on 28 Apr 2022
EPS came in at -$28.00 surpassing the estimated -$31.00 by +9.68%.
Earnings released on 2 Nov 2021
EPS came in at -$34.00 falling short of the estimated -$32.00 by -6.25%.
Earnings released on 5 Aug 2021
EPS came in at -$28.00 surpassing the estimated -$31.00 by +9.68%.
Earnings released on 3 May 2021
EPS came in at -$28.00 surpassing the estimated -$32.00 by +12.50%.
Earnings released on 6 Nov 2020
EPS came in at -$29.00 surpassing the estimated -$33.00 by +12.12%.
CBIO Stock Performance
Access detailed CBIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.